Immuron Company Leadership
IMRN Stock | USD 1.88 0.03 1.57% |
Immuron employs about 7 people. The company is managed by 6 executives with a total tenure of roughly 6 years, averaging almost 1.0 years of service per executive, having 1.17 employees per reported executive. Analysis of Immuron's management performance can provide insight into the firm performance.
Jerry Kanellos CEO Interim CEO, Chief Operating and Scientific Officer |
Immuron |
Immuron Management Team Effectiveness
The company has return on total asset (ROA) of (0.1737) % which means that it has lost $0.1737 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.4292) %, meaning that it created substantial loss on money invested by shareholders. Immuron's management efficiency ratios could be used to measure how well Immuron manages its routine affairs as well as how well it operates its assets and liabilities. As of the 26th of November 2024, Return On Tangible Assets is likely to drop to -0.47. In addition to that, Return On Capital Employed is likely to drop to -0.47. At this time, Immuron's Non Current Assets Total are very stable compared to the past year. As of the 26th of November 2024, Non Currrent Assets Other is likely to grow to about 702.7 K, while Total Assets are likely to drop about 9.3 M.As of the 26th of November 2024, Common Stock Shares Outstanding is likely to grow to about 239.6 M, while Net Loss is likely to drop (3.6 M).
Immuron Workforce Comparison
Immuron Ltd ADR is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 601. Immuron claims roughly 7.0 in number of employees contributing just under 2% to equities under Health Care industry.
The company has Profit Margin (PM) of (1.41) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.32) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.32. Immuron Ltd ADR Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. Immuron Ltd ADR Price Series Summation is a cross summation of Immuron price series and its benchmark/peer.
Immuron Notable Stakeholders
An Immuron stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Immuron often face trade-offs trying to please all of them. Immuron's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Immuron's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Jerry Kanellos | Interim CEO, Chief Operating and Scientific Officer | Profile | |
CPA CPA | Chief Officer | Profile | |
BBus CA | CFO Sec | Profile | |
Dan Peres | Chief Officer | Profile | |
Flavio Palumbo | Chief Officer | Profile | |
David Lyon | Head Marketing | Profile |
About Immuron Management Performance
The success or failure of an entity such as Immuron Ltd ADR often depends on how effective the management is. Immuron management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Immuron management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Immuron management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (0.45) | (0.47) | |
Return On Capital Employed | (0.45) | (0.47) | |
Return On Assets | (0.45) | (0.47) | |
Return On Equity | (0.55) | (0.57) |
Immuron Workforce Analysis
Traditionally, organizations such as Immuron use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Immuron within its industry.Immuron Manpower Efficiency
Return on Immuron Manpower
Revenue Per Employee | 700.4K | |
Revenue Per Executive | 817.1K | |
Net Loss Per Employee | 991K | |
Net Loss Per Executive | 1.2M | |
Working Capital Per Employee | 2.6M | |
Working Capital Per Executive | 3M |
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immuron Ltd ADR. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immuron. If investors know Immuron will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immuron listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.80) | Revenue Per Share 0.88 | Quarterly Revenue Growth 1.086 | Return On Assets (0.17) | Return On Equity (0.43) |
The market value of Immuron Ltd ADR is measured differently than its book value, which is the value of Immuron that is recorded on the company's balance sheet. Investors also form their own opinion of Immuron's value that differs from its market value or its book value, called intrinsic value, which is Immuron's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immuron's market value can be influenced by many factors that don't directly affect Immuron's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immuron's value and its price as these two are different measures arrived at by different means. Investors typically determine if Immuron is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immuron's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.